Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits--study
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
... The agency told doctors to prioritize getting those doses to infants at the highest risk of severe RSV, including infants younger than 6 months and those with underlying conditions. The CDC also advised doctors to preserve 50 mg doses for infants who weigh less than 11 pounds.
Submitted by mike kraft on
t
...
Submitted by mike kraft on
The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. That’s 2.6 times higher than the $530-per-course price paid by the US government, which provided Paxlovid free to patients during the pandemic. The Wall Street Journal first reported the new price.
Submitted by mike kraft on
... in Chest, a review of intensive care units (ICUs) across 10 Brazilian states shows that those with lower mortality rates pre-pandemic saw lower COVID-19 death rates.
Moreover, efficiently managed ICUs also saw lower mortality from the novel coronavirus, suggesting that hospital management is directly linked to patient outcomes.
...
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Major drug companies including Johnson & Johnson, Merck and Bristol Myers Squibb have committed to participate in Medicare drug price negotiations with the federal government, the Biden administration said Tuesday.
...
Submitted by mike kraft on
...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.
...